BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

CAPS Rating: 1 out of 5

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

Recs

0
Player Avatar TerryHogan (99.95) Submitted: 1/5/2013 3:00:34 AM : Underperform Start Price: $1.66 BCRX Score: +18.98

Tempted to say "It's got nowhere to go but up". But I think they're just going to burn through cash like a flamethrower attached to an apache helicopter piloted by Ben Bernanke.

Featured Broker Partners


Advertisement